S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 30,650
-1,650 (-5.11%)
At close: Feb 6, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 379.6 billion as of February 6, 2026. Its market cap has increased by 50.67% in one year.
Market Cap
379.60B
Enterprise Value
382.87B
Revenue
16.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
30,650.00
Market Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 379.60B, an increase of 83.77%. That is a compound annual growth rate of 24.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 379.60B | -16.29% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 548.08B |
| ToolGen | 488.11B |
| GC Cell | 365.91B |
| NIBEC | 350.61B |
| Y-Biologics | 346.06B |
| ABION | 306.79B |
| Genome & Company | 262.77B |
| curacle co.,ltd. | 256.21B |